Table of contents

Electronic pages

• 001 Ulnar neuropathy with abnormal non-localising electrophysiology: clinical, electrophysiological and ultrasound findings (24 May, 2018)

  Luciana Pelosi, Dominic Ming Yin Tse, Eoin Mulroy, Andrew M Chancellor, Michael R Boland
• 002 Persistent improvement in door-to-needle times after implementation of the helsinki protocol for routine acute stroke care (24 May, 2018)

  Matthew Silsby, Stephen R Duma, Alessandro F Fois, Joanna Koryzna, Neil Mahant, Andrew Evans, Victor SC Fung
• 003 A markov/multi-state model of progression and dynamics of seizure freedom in in large cohort of patients with epilepsy (24 May, 2018)

  Hugh D Simpson, Zhibin Chen, Patrick Kwan, Martin Brodie
• 004 Mechanisms of nerve dysfunction in inflammatory neuropathies (24 May, 2018)

  Nidhi Garg, Susanna B Park, James Howells, Con Yiannikas, Steve Vucic, Yu-ichi Noto, Arun V Krishnan, Judith Spies, Emily K Mathey, John D Pollard, Matthew C Kiernan
• 005 Filling in the gaps: precision MRI reporting in multiple sclerosis clinical practice (24 May, 2018)

  Heidi Beadnall, Yael Barnett, Linda Ly, Chenyu Wang, Thibo Billiet, Annemie Ribbens, Wim Van Hecke, Lynette Masters, Todd A Hardy, Michael H Barnett
• 006 Effect of apolipoprotein e ε4 allele on medial temporal lobe atrophy in ischaemic stroke patients (24 May, 2018)

  Mohamed Salah Khlif, Emilio Werden, Natalia Egorova, Wasim Khan, Amy Brodtmann
• 007 The impact of demographic changes on the presentation and outcome of stroke: experiences of the oldest old in the murrumbidgee region (24 May, 2018)

  Alice Powell, Paul Finucane, Martin Jude, Jenna Mewburn, Katherine Mohr, Stephen Kerr
• 008 Revascularisation surgery for non-moyamoya symptomatic intracranial stenosis and occlusion (24 May, 2018)

  Marcus Stoodley, Jeffrey Rogers, Manuri Gunawardena, Michael Morgan
• 009 The ambulance clinical triage-for acute stroke treatment (ACT-FAST) algorithmic pre-hospital triage tool for endovascular thrombectomy: ongoing paramedic validation (24 May, 2018)

  Henry Zhao, Lauren Pesavento, Edrich Rodrigues, Patrick Salvaris, Karen Smith, Stephen Bernard, Michael Stephenson, Mark Parsons, Nawaf Yassi, Stephen M Davis, Bruce CV Campbell
• 010 The melbourne mobile stroke unit substantially improves thrombolysis times and pre-hospital triage (24 May, 2018)

  Henry Zhao, Skye Coote, Lauren Pesavento, Francesca Langenberg, Patricia Desmond, Damien Easton, Lindsay Bent, Shane Foster, Michael Stephenson, Karen Smith, Stephen Bernard, Christopher Bladin, Dominique Cadilhac, Bernard Yan, Bruce CV Campbell, Mark Parsons, Geoffrey Donnan, Stephen M Davis
• 011 Ex-vivo generation of plasmin from patients with acute ischaemic stroke is predictive of successful thrombolysis (24 May, 2018)

  Chris Levi, Thomas Lillicrap, Stevi Harman, Dominik Draxler, Be’Eri Niego, Heidi Ho, Fiona McCutcheon, Timothy Kleinig, Simon Koblar, Monica Anne Hamilton-Bruce, Carlos Garcia-Esperon, Lisa Lincz, Andrew Bivard, John Attia, Jane Maguire, Elizabeth Holliday, Robert Medcalf
• 012 Cost-effectiveness of long-term continuous monitoring with an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke: an australian payer perspective (24 May, 2018)

  Vincent Thijs, Carmel Guarnieri, Koji Makino, Dominic Tilden, Marianne Huynh
• 013 Lipid metabolism and body composition in frontotemporal dementia-amyotrophic lateral sclerosis spectrum: effect on survival and disease progression (24 May, 2018)

  Rebekah M Ahmed, Elizabeth Highton-Williamson, Jashelle Caga, Nicollette Thornton, Eleanor Ramsey, Margaret Zoing, Olivier Piguet, John Hodges, Glenda Halliday, Sadaf Farooqi, Matthew C Kiernan
• 014 The diagnostic odyssey for fabry disease: ten years experience in testing (24 May, 2018)

  Julia Dobbins, Maria Fuller, Tim Pyragius, Kristian Brion, Sharon Chin, Melissa Gurner, Janina Pacyna, Samantha Stark, Janice M Fletcher
• 015 Predicting a diagnosis of pathologically confirmed vasculitic neuropathy (24 May, 2018)

  Dev Nathani, Michael H Barnett, Judith Spies, John Pollard, Matthew C Kiernan
• 016 What is the actual prevalence of migraine? (24 May, 2018)

  Wei Z Yeh, Leigh Blizzard, Bruce V Taylor
• 017 Paradoxical reaction in tuberculous meningitis: a tertiary referral hospital retrospective experience of concomitant immunosuppression therapy (24 May, 2018)

  David Ledingham, Shadi El-Wahsh, Cecilia Cappelen-Smith, Suzanne Hodgkinson, Alan McDougall, Michael Maley, Dennis Cordato
• 018 Management of migraine in the australian emergency department (24 May, 2018)

  Lakshini Gunasekera, Christina Sun-Edelstein, John Heywood, Lauren Sanders
• 019 Correlation of visual field loss with mri findings in patients with pituitary tumours (24 May, 2018)

  Christian J Lueck, Emily Kane, David Ashton, Peter Mews, Kate Reid, Andrew J Neely
• 020 Postural sway as a measure of disease severity in parkinson’s disease (24 May, 2018)

  Christian J Lueck, Susanne Ilschner, Alex Smith, Robin Vlieger, Chandi P Das, Jeff CL Looi, Deborah Apthorp
• 021 Clinical implications of cortical dysfunction in motor neuron disease: a combined structural and functional approach (24 May, 2018)

  Thanuja Dharmadasa, Neil G Simon, Chenyu Wang, Steve Vucic, Matthew C Kiernan
• 022 Piloting home infusions of natalizumab: a randomised crossover trial (24 May, 2018)

  Tim Schultz, Anne Thomas, Paul Georgiou, Mahasen Juaton, Lorraine Simon, Lynette Cusack, Kerisha Naidoo, Kevin Webb, Jon Karnon, Janakan Ravindran
• 024 Longitudinal diffusion tensor imaging in the primary progressive aphasias (24 May, 2018)

  Colin J Mahoney, Ivor JA Simpson, Jennifer M Nicholas, Jonathan D Rohrer, Jason D Warren
• 025 The neural correlates of doorway freezing in parkinson’s disease (24 May, 2018)

  Elie Matar, James M Shine, Moran Gilat, Kaylena Ehgoetz-Martens, Phillip B Ward, Michael J Frank, Ahmed Moustafa, Sharon L Naismith, Simon JG Lewis
• 026 Characteristics of advanced parkinson’s disease patients seen in movement disorder clinics – australian results from the cross-sectional observe study (24 May, 2018)

  Andrew Evans, Victor SC Fung, John O’Sullivan, Rick Stell, Richard White, David Williams, Koray Onuk
• 027 Lightning injuries: keraunoparalysis and other neurologic manifestations (24 May, 2018)

  Wai Foong Hooi, Gabrielle Tse, John Waterston
• 028 Treating progressive multiple sclerosis (24 May, 2018)

  Jordana Hughes, Vilija Jokubaitis, Mark Slee, Jeannette Lechner-Scott, Anneke Van der Walt, Helmut Butzkueven, Tomas Kalincik
• 029 Multiple-acyl-coa dehydrogenase deficiency (MADD): a rare but treatable genetic metabolic myopathy (24 May, 2018)

  Wai Foong Hooi, Christopher Kyndt, Mark Faragher, Bruce Day
• 030 A rapidly progressive dermatomyositis with fatality – lessons to learn (24 May, 2018)

  Fariha Islam, Abhishek Malhotra, Anish Sachdev
• 031 Investigating motor evoked potentials as a biomarker for disease severity in hereditary spastic paraplegia (24 May, 2018)

  Sue-Faye Siow, Carolyn Sue, Kishore Kumar, Sharon Coward, Amy Lofts, Karl Ng
• 032 Neurological sequelae of immune checkpoint inhibitors: a case series (24 May, 2018)

  Matthew Silsby, Stephen R Duma, Neil Mahant, Steve Vucic, Andrew Henderson
• 033 Effect of ocrelizumab on upper limb function in patients with primary progressive multiple sclerosis (PPMS) in the oratorio study (ENCORE) (24 May, 2018)

  Edward Fox, Clyde Markowitz, Angela Applebee, Xavier Montalban, Jerry S Wolinsky, Shebeshih Belachew, Damian Fiore, Jian Han, Bruno Musch, Gavin Giovannoni
• 034 The susceptibility vessel sign: a clinical-radiological case of propagating left MCA thrombus with resolving neurological deficits (24 May, 2018)

  Benjamin Nham, Simon Hawke
• 035 Interferon beta induced thrombotic microangiopathy in multiple sclerosis: a clinical-pathological report (24 May, 2018)

  Charmaine Yam, Anthony Fok, Catriona McLean, Ernest Butler, Peter Kempster
• 036 Mobile intraluminal long segment carotid thrombus causing ischaemic stroke (24 May, 2018)

  Benjamin Nham, Simon Hawke
• 037 Post-transplant lymphoproliferative disorder in skeletal muscle arising seven years after allogeneic stem cell transplant (24 May, 2018)

  Alice Powell, Joanne Sy, Yael Barnett, Simon Mosalski, Bruce Brew, Keith Fay, Susan Tomlinson
• 038 Adult-onset leukoencephalopathy with neuroaxonal spheroids and pigmented glia mimicking systemic lupus erythematosus cerebral vasculitis (24 May, 2018)

  Michal Lubomski, Michael Buckland, Joanne Sy, Heng Wei, Irene Tan, Barry Kane, Penelope J Spring
• 039 Rates of lymphopenia in years 1–4 in patients with relapsing multiple sclerosis treated annually with cladribine tablets (24 May, 2018)

  Stuart Cook, Giancarlo Comi, Gavin Giovannoni, Peter Rieckmann, Per Soelberg Sorensen, Patrick Vermersch, Fernando Dangond, John King, Christine Hicking
• 040 An analysis of malignancy risk in the clinical development programme of cladribine tablets in patients with relapsing multiple sclerosis (24 May, 2018)

  Andrew Galazka, Axel Nolting, Stuart Cook, Thomas Leist, Giancarlo Comi, Xavier Montalban, Christine Hicking, John King, Fernando Dangond
• 041 Predictors of clinical outcomes in patients with brain abscess (24 May, 2018)

  Thanyalak Amornpojnimman, Pat Korathanakhun
• 042 Chronic inflammatory demyelinating polyneuropathy presenting as focal amyotrophy (24 May, 2018)

  Shadi El-Wahsh, Dennis Cordato, Con Yiannikas
• 043 Rheumatoid leptomeningitis: an acute presentation of neuropsychiatric disturbance (24 May, 2018)

  Michal Lubomski, Joanne Sy, Michael Buckland, Andie S Lee, Bethan Richards, Elizabeth Thompson, Michael Fulham, Michael Halmagyi
• 044 Durable clinical efficacy of alemtuzumab in patients with active rrms in the absence of continuous treatment: 7-year follow-up of CARE-MS I patients (Topaz Study) (24 May, 2018)

  Pamela McCombe, Alexey N Boyko, Jérôme DeSeze, Hans-Peter Hartung, Eva Havrdova, Jihad Said Inshasi, Xavier Montalban, Carlo Pozzilli, Krzysztof W Selmaj, Patrick Vermersch, Maria Melanson, Nadia Daizadeh, Claudio E Rodriguez, Bart Van Wijmeersch, on behalf of the CARE-MS I, CAMMS03409, and TOPAZ Investigators
• 045 Delayed-release dimethyl fumarate demonstrated no difference in clinical outcomes versus fingolimod in patients with relapsing-remitting multiple sclerosis: results from the real-world effect study (24 May, 2018)

  Jacob Sloane, J Theodore Phillips, Jonathan Calkwood, Anneke Van der Walt, Jinny Min, Macaulay Okwuokenye, Catherine Taylor
• 046 Efficacy and safety of intravenous immunoglobulin (IVIG) IGPRO10 in chronic inflammatory demyelinating polyneuropathy (CIDP) (24 May, 2018)

  Arman Sabet, Orell Mielke, Ivo N van Schaik, Jean-Marc Leger, Vera Bril, Nan van Gloven, Hans Peter Hartung, Richard A Lewis, Gen Sobue, John-Philip Lawo, Billie L Durn, David R Cornblath, Jan LDe Bleecker, Claudia Sommer, Wim Robberecht, Mika Saarela, Jerzy Kamienowski, Zbigniew Stelmasiak, Bjorn Tackenberg, Ingemar SJ Merkies
• 047 Creutzfeld-jakob disease with prolonged disease course in two younger patients (24 May, 2018)

  Roshan Dhanapalaratnam, Roy Beran, Michael Buckland, Cecilia Cappelen-Smith
• 048 Large pseudo-meningocele causing severe papilledema, retinal haemorrhages and recurrent positional syncope (24 May, 2018)

  Wai Foong Hooi, John Waterston
• 049 Lower stimulus contrast is associated with stronger multifocal visual evoked potential signals (24 May, 2018)

  Joshua L Barton, Michael H Barnett, Alexander Klistorner
• 050 Latitude continues to be associated with ms prevalence: an updated meta-analysis (24 May, 2018)

  Wendy Wang, Steve Simpson, Bruce Taylor
• 051 Systematic review of CT angiographic ‘spot sign’ for predicting mortality (24 May, 2018)

  Natasha Krishnadas, Thanh G Phan, Vivian WY Lai, Michael J Batt, Ronil V Chandra, Velandai Srikanth, Henry Ma
• 052 Diagnostic accuracy of the CT angiographic ‘spot sign’ for predicting intracerebral haematoma growth (24 May, 2018)

  Natasha Krishnadas, Thanh G Phan, Vivian WY Lai, Michael J Batt, Ronil V Chandra, Velandai Srikanth, Henry Ma
• 053 Pregnancy outcomes with delayed-release dimethyl fumarate: interim results from an international registry (24 May, 2018)

  Nicholas J Everage, Shifang Liu, Jang Yun, Claudia Prada, Jerome Hanna
• 054 Disability improvement is observed in each functional system in alemtuzumab-treated patients with active RRMS: results from CARE-MS II extension (24 May, 2018)

  Richard AL Macdonell, Rany A Aburashed, Raed Alroughani, Dominique Dive, Guillermo Izquierdo, Ho-Jin Kim, Jan Lycke, Carlo Pozzilli, Basil Sharrack, Patrick Vermersch, Heinz Wiendl, Andreas Lysandropoulos, Luke Chung, Nadia Daizadeh, Samuel F Hunter, on behalf of the CARE-MS II and CAMMS03409 Investigators
• 055 Effect of common concomitant antiepileptic drugs during adjunctive treatment with perampanel: post hoc analysis from the open-label extension of a phase III study in patients with idiopathic generalised epilepsy (24 May, 2018)

  Terence J O’Brien, Francesco Bibbiani, Anna Patten, Antonio Laurenza, Betsy Williams
• 056 Perampanel and secondarily generalised seizures in a pooled analysis of phase III studies and their open-label extension: effect of enzyme-inducing antiepileptic drugs (24 May, 2018)

  David Ko, Betsy Williams, Anna Patten, Antonio Laurenza
• 057 Real world evidence (RWE) on long-term persistence of fingolimod in relapsing-remitting multiple sclerosis (RRMS) in australia (24 May, 2018)

  Robert Walker, Mark Schulz, Birendra Arora, Eric Chung, Prabhjot Juneja, Stephane Verhaeghe, Tim Spelman, Simon Broadley
• 058 ANTI-CASPR2-ANTIBODY associated encephalitis in a 63-year old male with chronic lymphocytic leukaemia (24 May, 2018)

  Kate Lilley, Andrew Swayne, Emily Watson, Rachel Kee, David Wong, Alexander Lehn, Helen Brown, Cullen O’Gorman, Nabeel Sheikh, Robert Bird, Kerri Prain, David Gillis, Richard C Wong, Stefan Blum
• 059 Teratoma with glycine, NMDA & VGKC antibodies presenting with severe weakness, respiratory failure & corticospinal tract dysfunction (24 May, 2018)

  Andrew Swayne, Cullen O’Gorman, Nabeel Sheikh, Helen Brown, Lyndall Buck, Kerri Prain, David Gillis, Richard Wong, Stefan Blum
• 060 Association of brain volume loss and neda outcomes in patients with relapsing multiple sclerosis in the opera i and opera ii studies (ENCORE) (24 May, 2018)

  Anthony Traboulsee, Douglas Arnold, Eric C Klawiter, Eva Havrdova, Damian Fiore, Ray Zheng, Laura Julian, Gavin Giovannoni
• 061 Ocrelizumab reduces disability progression independent of relapse activity in patients with relapsing multiple sclerosis (RMS) (ENCORE) (24 May, 2018)

  Ludwig Kappos, Jerry S Wolinsky, Gavin Giovannoni, Douglas L Arnold, Fred Lublin, Qing Wang, Fabian Model, Wei Wei, Hideki Garren, Marianna Manfrini, Shibeshih Belachew, Stephen Hauser
• 062 Cadasil presenting with focal and generalised epilepsy due to a novel NOTCH3 mutation (24 May, 2018)

  Benson S Chen, James C Cleland, Richard I King, Neil E Anderson
• 063 Actinomyces cavernous sinus infection: a case and systematic literature review

  (24 May, 2018)

  Michal Lubomski, James Dalgliesh, Kenneth Lee, Omprakash Damodaran, Genevieve McKew, Stephen Reddel
• 064 Expert consensus on standards for multiple sclerosis care: results from a modified delphi process (24 May, 2018)

  Helmut Butzkueven, Jeremy Hobart, Amy Bowen, Lucy Eberhard, George Pepper, Gavin Giovannoni
• 065 A pilot time and motion study for treatments of relapsing remitting multiple sclerosis (RRMS) in australia (24 May, 2018)

  Jeanette Lechner-Scott, Ryan Davey, Peter Davey, Goce Bogeski, Esther Cheah
• 066 Impact of long-term teriflunomide treatment on lymphocyte counts and infections in pooled temso and tower studies (24 May, 2018)

  Giancarlo Comi, Richard Macdonell, Myriam Benamor, Philippe Truffinet, Karthinathan Thangavelu, Matt Mandel, Mark S Freedman
• 067 Efficacy of cladribine tablets in patients with highly active relapsing-remitting multiple sclerosis: analysis of pooled double-blind data from the clarity and onward studies (24 May, 2018)

  Gavin Giovannoni, Xavier Montalban, Kottil Rammohan, Stuart Cook, Giancarlo Comi, Peter Rieckmann, Per Soelberg-Sorensen, Patrick Vermersch, Fernando Dangond, John King, Doris Damian
• 068 Evaluation of the long-term treatment effect of teriflunomide on cognitive outcomes and association with brain volume change: data from temso and its extension study (24 May, 2018)

  Till Sprenger, Jeannette Lechner-Scott, Maria P Sormani, Jerry S Wolinsky, Jens Wuerfel, Karthinathan Thangavelu, Steven Cavalier, Matt Mandel, Ludwig Kappos
• 069 Peginterferon beta-1a improves clinical and radiological disease outcomes in patients who are newly diagnosed with relapsing-remitting multiple sclerosis (RRMS): subgroup analysis of advance (24 May, 2018)

  Scott D Newsome, Douglas L Arnold, Jang Yun, Matthias Meergans, Maria L Naylor
• 070 Baseline characteristics and safety profile of patients with relapsing-remitting multiple sclerosis (RRMS) in the first interim analysis of the peginterferon BETA-1A treatment in the phase 4 plegridy observational program (POP) (24 May, 2018)

  Marco Salvetti, Jang Yun, David Appiah-Badu, Guido Sabatella, Maria L Naylor
• 071 Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the touch^® prescribing program

  (24 May, 2018)

  Lana Zhovtis Ryerson, John Foley, Ih Chang, Ilya Kister, Gary Cutter, Ryan Metzger, Judith D Goldberg, Xiaochun Li, Evan Riddle, Karen Smirnakis, Bei Yu, Zheng Ren, Christophe Hotermans, Pei-Ran Ho, Nolan Campbell
• 072 Clinical audit of stroke admissions associated with atrial fibrillation and anticoagulation rates (24 May, 2018)

  Zainab Khan, Sumana Gopinath, Stanley Levy
• 073 Alemtuzumab induced allergic inflammatory syndrome (ALIAS) with eosinophilic acalculous cholecystitis: a report of two cases (24 May, 2018)

  Ariadna Fontes-Villalba, John DE Parratt
• 074 First seizures in emergency department vs ward: study in an elderly population (24 May, 2018)

  Emma Foster, Sarah Holper, Patrick Kwan
• 075 Association between intracranial stenosis and extracranial stenosis seen in stroke patients (24 May, 2018)

  Geetha Guduguntla, Cheng Ling Ting, Tarun Jain, Yash Gawarikar, Ronak Patel
• 076 The expanding clinical phenotype of NMDAR encephalitis (24 May, 2018)

  Jessica Qiu, Jacob Helou, Nicholas Urriola, Miriam Welgampola, John Parratt, Toh Hock Wong, Kaitlyn Parratt
• 077 Recurrent guillain-barre syndrome (24 May, 2018)

  Wai Foong Hooi, Elspeth Hutton, Bruce Day
• 078 Deep brain stimulation (DBS) for dyskinetic cerebral palsy: a pilot study (24 May, 2018)

  Stephen R Duma, Neil Mahant, Ainhi Ha, Samuel Kim, Amy Phu, Kirsty Stewart, Mary-Clare Waugh, Nigel Wolfe, Dale C Russell, Brian Owler, Martin Krause, Victor SC Fung
• 079 Nerve ultrasound cross sectional area does not correlate with electrodiagnostic carpal tunnel severity in the very elderly (24 May, 2018)

  Eoin Mulroy, Luciana Pelosi
• 080 Electrodiagnostic and ultrasound correlates of clinical severity in ulnar neuropathy (24 May, 2018)

  Luciana Pelosi, Eoin Mulroy
• 081 Description of a stroke unit mimic admissions (24 May, 2018)

  Catelyn Cashion, Yash Gawarikar, Ronak Patel
• 082 Real world experience of treating multiple sclerosis with alemtuzumab (24 May, 2018)

  Ellie Khalili, Brent Venning, Mike Boggild, Simon A Broadley
• 083 Response to immunosuppressive therapy in cerebral amyloid angiopathy-related inflammation (24 May, 2018)

  Jasmin Tilling, Benjamin Trewin, Stanley Levy
• 084 Treating yourself: a glucocorticoid secreting tumour suppressing myasthenia gravis (24 May, 2018)

  Andrew Swayne, Michael Lane, Helen Brown, Kerri Prain, Richard Wong, David Gillis, Stefan Blum
• 085 Clinical outcomes were better for relapsing-remitting multiple sclerosis (RRMS) patients who remained on natalizumab compared to those who switched to oral or injectable therapies after 2 years in the tysabri^® observational program (TOP)

  (24 May, 2018)

  Helmut Butzkueven, Ludwig Kappos, Tim Spelman, Maria Trojano, Heinz Wiendl, Qunming Dong, Stephanie Licata, Pei-Ran Ho, Nolan Campbell
• 086 The rapid efficacy of natalizumab vs fingolimod in patients with active relapsing-remitting multiple sclerosis (RRMS): results from reveal, a randomised, head-to-head study (24 May, 2018)

  Helmut Butzkueven, Douglas Jeffery, Douglas L Arnold, Massimo Filippi, Jeroen JG Geurts, Qunming Dong, Nolan Campbell, Stephanie Licata, Pei-Ran Ho
• 087 Cerebral fat embolism in a case of endoscopic oesophageal dilatation (24 May, 2018)

  Andrew Clarke, Wilson Vallat, Timothy Kleinig
• 088 Cryoglobulinemic neuropathy associated with lymphoplasmacytic lymphoma (24 May, 2018)

  Yew Li Dang, Emma Foster, Moira Finlay, Andrew Evans
• 089 Prognostic significance of magnetic resonance imaging in patients with severe non-penetrating traumatic brain injury requiring decompressive craniectomy (24 May, 2018)

  Kwok-Ming Ho, Stephen Honeybul, Ravi Ambati
• 090 The expanding clinical phenotype of late onset pompe disease: a multi-system disorder (24 May, 2018)

  Katrina Reardon, Penny McKelvie
• 091 Poems syndrome treated with autologous stem cell transplant (24 May, 2018)

  Michael Devlin, Craig Costello, Georgina Hodges, Ravindra Urkude
• 092 Early-onset dementia with white matter changes (24 May, 2018)

  Benjamin P Trewin, Jono Baskin, Laveniya Satgunaseelan, Stanley Levy
• 093 Clinical and imaging discordance in reversible cerebral vasoconstriction syndrome (24 May, 2018)

  Michael J Devlin, Archana Dwivedee, Richard P White
• 094 Vascular targeting of phosphatidylserine causing thrombotic occlusion in an arteriovenous malformation animal model (24 May, 2018)

  Marcus Stoodley, Andrew Gauden, Vivienne Lee, Sinduja Subramanian, Vaughan Moutrie, Zhenjun Zhao, Lucinda McRobb
• 095 Increased incidence of moyamoya angiopathy in northern queensland (24 May, 2018)

  Emma L Harrison, Michael J Devlin, Marcus A Stoodley, Richard P White
• 096 A 47-year old female with slowly progressive cognitive impairment and motor decline (24 May, 2018)

  Wilson Vallat, Timothy Kleinig
• 097 A rare case of recurrent transient global amnesia (24 May, 2018)

  Sameer Saleem, Ronak Patel, Yash Gawarikar
• 098 A case of myasthenia gravis lambert eaton overlap syndrome (MLOS) in seronegative myasthenia gravis (24 May, 2018)

  Sameer Saleem, Ronak Patel, Yash Gawarikar
• 099 A case of possible Fahr’s disease (24 May, 2018)

  Sameer Saleem, Yash Gawarikar, Ronak Patel
• 100 Autoimmune lambert eaton myasthenic syndrome in young adults (24 May, 2018)

  Antony Winkel, Katrina Reardon, Leslie Roberts
• 101 Dispelling the curse: improvement of ventilatory drive in central alveolar hypoventilation syndrome after medullary infarction (24 May, 2018)

  Marco Fedi, Shi Hong Shen, Bruce Campbell, Mathias Dutschmann, Terrence O’brien, James Anstey, Christopher MacIsaac
• 102 Alemtuzumab associated thrombocytopenia: a case series (24 May, 2018)

  Aaron Gaekwad, Andrew Lee
• 103 Exploring the influence of quantitative magnetic resonance imaging on decision-making in multiple sclerosis clinical practice (24 May, 2018)

  Heidi N Beadnall, Linda Ly, Chenyu Wang, Thibo Billiet, Annemie Ribbens, Wim Van Hecke, Robert Zivadinov, Michael H Barnett
• 104 Severe unilateral optic neuritis in multiple sclerosis (24 May, 2018)

  Natasha Gerbis, John Parratt
• 105 Snake eyes in the thoracic spine (24 May, 2018)

  Joel Corbett, Stephen Walsh, Sandeep Bhuta, Arman Sabet
• 106 Post-traumatic neuromyelitis optica spectrum disorder (24 May, 2018)

  Natasha Gerbis, John Parratt, Christina Liang
• 107 First come, first served: a comparison of first-ever seizure patients and those presenting after recurrent-untreated seizures (24 May, 2018)

  Sarah Holper, Emma Foster, Patrick Kwan
• 108 Longitudinally extensive transverse myelitis as the sole manifestation of sarcoidosis (24 May, 2018)

  Ariadna Fontes-Villalba, John Parratt
• 109 Investigation of natural killer cell function and phenotypes in stable and active multiple sclerosis patients (24 May, 2018)

  Elham Khalilidehkordi, Helene Cabanas, Natalie Eaton, Simon Broadley, Cassandra Balinas, Stanley Du Preez, Rebekah Maksoud, Donald Staines, Sonya Marshall-Gradisnik
• 110 Atrophy of the mediodorsal thalamus is associated with visual hallucinations in lewy body diseases (24 May, 2018)

  Elie Matar, Daniel Brooks, Antony Harding, Glenda Halliday
• 111 Epileptic seizures in multiple sclerosis (24 May, 2018)

  Stephen Walsh, Joel Corbett, K Meng Tan, Simon Broadley
• 112 Blood spot testing for late onset pompe disease (24 May, 2018)

  Julia Dobbins, Tim Pyragius, Kristian Brion, Sharon Chin, Melissa Gurner, Janina Pacyna, Samantha Stark, Janice M Fletcher
• 113 Rituximab and maintenance mycophenolate mofetil for treatment of refractory ANTI-N-METHYL-D-ASPARTATE-receptor (NMDAR) encephalitis (24 May, 2018)

  Leon S Edwards, Michael H Barnett, Matthew C Kiernan